Literature DB >> 23171462

The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression.

Ivan V Litvinov, Thomas S Kupper, Denis Sasseville.   

Abstract

Cutaneous T-cell lymphoma (CTCL) is the most common lymphoma of the skin. Recent reports suggest that AHI1 is overexpressed in a subset of CTCL-derived cell lines, where it downregulates the expression of CDKN1C tumor suppressor gene. In the current work, we test the expression of these genes in 60 patients with Mycosis Fungoides and Sezary Syndrome by RT-PCR and correlate our findings with 6 years of clinical follow-up. These findings reveal that AHI1 and CDKN1C exhibit opposite expression patterns, where AHI1 is expressed in poor and intermediate prognosis patients, while CDKN1C is expressed in favourable prognosis patients. Kaplan-Meier analysis documents that downregulation of CDKN1C is associated with poor disease outcome in patients with CTCL, while upregulation of AHI1 shows a weak association with aggressive disease course.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23171462      PMCID: PMC5215484          DOI: 10.1111/exd.12039

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  11 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop.

Authors:  S I Lamberg; P A Bunn
Journal:  Arch Dermatol       Date:  1979-09

3.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

4.  Clonal heterogeneity in mycosis fungoides and its relationship to clinical course.

Authors:  Francisco Vega; Rajyalakshmi Luthra; L Jeffrey Medeiros; Valerie Dunmire; Sang-Joon Lee; Madeleine Duvic; Dan Jones
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma.

Authors:  Ivan V Litvinov; David A Jones; Denis Sasseville; Thomas S Kupper
Journal:  Clin Cancer Res       Date:  2010-03-16       Impact factor: 12.531

6.  A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.

Authors:  Marloes S van Kester; Martin K Borg; Willem H Zoutman; Jacoba J Out-Luiting; Patty M Jansen; Enno J Dreef; Maarten H Vermeer; Remco van Doorn; Rein Willemze; Cornelis P Tensen
Journal:  J Invest Dermatol       Date:  2012-04-19       Impact factor: 8.551

Review 7.  The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.

Authors:  D N Slater
Journal:  Br J Dermatol       Date:  2005-11       Impact factor: 9.302

8.  Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.

Authors:  Erin Kennah; Ashley Ringrose; Liang L Zhou; Sharmin Esmailzadeh; Hong Qian; Ming-wan Su; Youwen Zhou; Xiaoyan Jiang
Journal:  Blood       Date:  2009-02-10       Impact factor: 22.113

9.  About the cutaneous targets of bexarotene in CTCL patients.

Authors:  Anne Chantal Knol; Gaëlle Quéreux; Anabelle Brocard; Fabienne Ballanger; Amir Khammari; Jean-Michel Nguyen; Brigitte Dréno
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

10.  Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome.

Authors:  Jessica Shin; Stefano Monti; Daniel J Aires; Madeleine Duvic; Todd Golub; David A Jones; Thomas S Kupper
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

View more
  14 in total

1.  Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients.

Authors:  Ivan V Litvinov; Brendan Cordeiro; Yuanshen Huang; Hanieh Zargham; Kevin Pehr; Marc-André Doré; Martin Gilbert; Youwen Zhou; Thomas S Kupper; Denis Sasseville
Journal:  Clin Cancer Res       Date:  2014-05-21       Impact factor: 12.531

2.  The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).

Authors:  Ivan V Litvinov; Elena Netchiporouk; Brendan Cordeiro; Marc-André Doré; Linda Moreau; Kevin Pehr; Martin Gilbert; Youwen Zhou; Denis Sasseville; Thomas S Kupper
Journal:  Clin Cancer Res       Date:  2015-03-16       Impact factor: 12.531

3.  Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Ivan V Litvinov; Yang Wang; Lixin Xia; Andreas Willerslev-Olsen; Sergei B Koralov; Katharina L Kopp; Charlotte M Bonefeld; Mariusz A Wasik; Carsten Geisler; Anders Woetmann; Youwen Zhou; Denis Sasseville; Niels Odum
Journal:  Blood       Date:  2013-06-25       Impact factor: 22.113

4.  Functional relevance for multiple sclerosis-associated genetic variants.

Authors:  Xiang Lin; Fei-Yan Deng; Xing-Bo Mo; Long-Fei Wu; Shu-Feng Lei
Journal:  Immunogenetics       Date:  2014-10-12       Impact factor: 2.846

5.  Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma.

Authors:  Ivan V Litvinov; Elena Netchiporouk; Brendan Cordeiro; Hanieh Zargham; Kevin Pehr; Martin Gilbert; Youwen Zhou; Linda Moreau; Anders Woetmann; Niels Ødum; Thomas S Kupper; Denis Sasseville
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

6.  Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.

Authors:  Ivan V Litvinov; Brendan Cordeiro; Simon Fredholm; Niels Ødum; Hanieh Zargham; Yuanshen Huang; Youwen Zhou; Kevin Pehr; Thomas S Kupper; Anders Woetmann; Denis Sasseville
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.

Authors:  Beverly W Baron; John Anastasi; Juraj Bies; Poluru L Reddy; Loren Joseph; Michael J Thirman; Kristen Wroblewski; Linda Wolff; Joseph M Baron
Journal:  Blood Cells Mol Dis       Date:  2013-07-30       Impact factor: 3.039

8.  IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).

Authors:  Andreas Willerslev-Olsen; Ivan V Litvinov; Simon M Fredholm; David L Petersen; Nina A Sibbesen; Robert Gniadecki; Qian Zhang; Charlotte M Bonefeld; Mariusz A Wasik; Carsten Geisler; Youwen Zhou; Anders Woetmann; Denis Sasseville; Thorbjørn Krejsgaard; Niels Odum
Journal:  Cell Cycle       Date:  2014-03-03       Impact factor: 4.534

9.  Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries.

Authors:  Ivan V Litvinov; Michael T Tetzlaff; Elham Rahme; Michelle A Jennings; David R Risser; Pamela Gangar; Elena Netchiporouk; Linda Moreau; Victor G Prieto; Denis Sasseville; Madeleine Duvic
Journal:  Cancer Med       Date:  2015-07-01       Impact factor: 4.452

10.  Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.

Authors:  Ieva Bagdonaite; Hans H Wandall; Ivan V Litvinov; Claudia Nastasi; Jürgen C Becker; Sally Dabelsteen; Carsten Geisler; Charlotte M Bonefeld; Qian Zhang; Mariusz A Wasik; Youwen Zhou; Denis Sasseville; Niels Ødum; Anders Woetmann
Journal:  Oncotarget       Date:  2015-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.